Abstract:BACKGROUND: N-acetylcysteine (NAC) is an antioxidant which can regenerate glutathione and is primarily used for acetaminophen overdose. It is also a potential therapy to prevent iatrogenic acute kidney injury or slow the progression of chronic kidney disease. It has been considered in this context by many studies with mixed results. Notably, a biological-mechanism rationale for a protective effect of NAC has never been adequately reported. Among conflicting reports, there appears to be evidence that NAC may artificially lower measured serum creatinine without improving kidney function, potentially by assay interference. Given these mixed results, a systematic review of the literature will be conducted to determine whether there is an effect of NAC on kidney function measured with serum creatinine.OBJECTIVE: To determine the effect of NAC on kidney function.DESIGN: A systematic review and meta-analysis.SETTINGS: Prospective studies, with administration of NAC, in the absence of any other change in kidney function (such as contrast administration or surgery).PATIENTS: Adult humans aged 18 years old or more, either healthy volunteers or with chronic kidney disease, were administered with NAC. Populations having little to no kidney function such as in end-stage kidney disease will be excluded.MEASUREMENTS: Serum creatinine and/or cystatin C measurements before and after NAC administration.METHODS: An information specialist will assist in searching MEDLINE, EMBASE, and the Cochrane CENTRAL databases to identify all study types including randomized controlled trials, and prospective cohort studies reporting change in serum creatinine after NAC administration. Two reviewers will independently screen the titles and abstracts of the studies obtained from the search using predefined inclusion criteria and will then extract data from the full texts of selected studies. The weighted mean difference will be calculated for change in creatinine with NAC, using random-effects analysis. Quality assessment will be done with the Cochrane Risk of Bias tool for randomized trials and the Newcastle-Ottawa Scale for observational studies.RESULTS: The outcome of interest is kidney function as reported by either change in serum creatinine and/or serum cystatin C measurement for randomized trials or comparing baseline (pre-NAC dose) values and those following the NAC dose.LIMITATIONS: Possible heterogeneity and publication bias and lack of mechanistic data.CONCLUSIONS: This systematic review will provide a synthesis of current evidence on the effect of NAC on serum creatinine measurement. These findings will provide clinicians with guidelines and serve as a strong research base for future studies in this field.SYSTEMATIC REVIEW REGISTRATION: This review is registered with PROSPERO, CRD42017055984.

Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice

Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project

[Clinical semiology associated with increased creatinine kinase in patients attending emergency department]

Acute Kidney Injury in Hospitalized Patients With Exertional Rhabdomyolysis

CREATINE KINASE IN PATIENTS WITH RHABDOMYOLYSIS ACUTELY INTOXICATED WITH PSYCHOTROPIC AND CHEMICAL SUBSTANCES

Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Relation between Serum Creatine Phosphokinase Levels and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients

Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation

Rhabdomyolysis with Acute Renal Failure and Deep Vein Thrombosis Induced by Antipsychotic Drugs: A Case Report

Approach to asymptomatic creatine kinase elevation

Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations

The potential role of creatine supplementation in neurodegenerative diseases

Serum Creatinine Levels May Not Necessarily Reflect a True Renal Function to Adjust Amikacin Dose in Paraplegic Patient: A Case Report and Literature Review

Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study

Effect of levetiracetam usage on serum creatine phosphokinase concentration in patients with epilepsy

A case control study of the relationship between persistent serum creatine kinase elevation and polyneuropathy

The Effect of N-Acetylcysteine on Creatinine Measurement: Protocol for a Systematic Review

Case report: One child with an autism spectrum disorder who had chronically elevated serum levels of CK and CK-MB

Physiologic Response to Exercise or Rhabdomyolysis? Creatine Phosphokinase Elevation in 16 Asymptomatic Firefighters

Relation of subclinical serum creatinine elevation to adverse in-hospital outcomes among myocardial infarction patients